علاج الخط الأول لليمفوما EMZL الملتحمة المثبتة بالخزعة مع مشاركة اللمفوما الجهازية

References

DOI: 10.1038/s41433-022-02176-2

• The gold standard of conjunctival lymphoma diagnosis is an incisional biopsy for histopathological and cytological examination.
• In the setting of conjunctival disease with evidence of lymphoma at other sites, systemic chemotherapy is often indicated.
• Nuckel and co-workers were the first to employ rituximab at an intravenous dose of 375 mg/m² weekly (for 4 weeks) in 2 patients with orbital disease, with a 50% complete response rate.
• Rituximab-chlorambucil should be recommended in EMZL patients requiring systemic therapy.